FDA approves Trulance for treatment of CIC

FDA approved Trulance (plecanatide), by Synergy Pharmaceuticals Inc., for the treatment of CIC (Chronic Idiopathic Constipation) in adult patients. The product works locally in the upper gastrointestinal tract to stimulate secretion of intestinal fluid and support regular bowel function. It is administered orally. The safety and efficacy of Trulance have been established in two clinical trials including 1,775 patients.
(Source FDA)